Article
12 May 2026
UPC Court Of Appeal Endorses EPO Approach To Inventive Step For Computer-Implemented Inventions
AUTHORS CONTENT
Article
28 Apr 2026
Advocate General Of The CJEU Indicates That An ‘excipient’ Cannot Be Regarded As An Active Ingredient For An SPC
Article
24 Apr 2026
Trans-Atlantic Alignment? US Federal Circuit Moves Closer To The EPO/UPC Approach For Broad Antibody Claims To Medical Uses
Article
22 Apr 2026
UPC Aligns Implicit Disclosure Test With EPO In SharkNinja v SEB
Article
30 Mar 2026
How The EU Is Re-Shaping The Regulation Of Gene-Edited Plants
Article
27 Mar 2026
English High Court Rules No SPC Based On Authorisation Of Monotherapy A Where A+B Was Authorised First
Article
27 Mar 2026
Gene Therapy And US Patent Eligibility Update: REGENXBIO, Inc. v. Sarepta Therapeutics, Inc.
Article
18 Mar 2026
G 1/25: Enlarged Board Of Appeal Issues Preliminary Opinion On Amendment Of The Description
Article
18 Mar 2026
Essential Reading For Plant IP Enthusiasts: Nador Cott Protection SAS V Asda Stores Limited – [2026] EWHC 553 (Pat)
Article
13 Mar 2026
Dyson v Dreame: UPC Court Of Appeal Refers Long-arm Jurisdiction Questions To CJEU
Article
11 Mar 2026
New Referral To The Enlarged Board Of Appeal Expected Regarding Claim Interpretation In The Context Of Added Subject Matter
Article
11 Mar 2026
Unitary Patents Unavailable Unless Granted For All UPC Participating States
Article
06 Mar 2026
UKIPO To Increase Official Fees From 1 April 2026
Article
05 Mar 2026
New EU Funding Available For IP Costs Of SMEs Established In The EU And Ukraine
Article
25 Feb 2026
Oral Proceedings Scheduled For 'Description Amendments' Enlarged Board Of Appeal Case G1/25
Article
26 Jan 2026
UPC Issues Preliminary Injunction In Consumer Products Dispute
Article
19 Jan 2026
EPO To Use AI To Prepare Minutes For All Examination And Opposition Oral Proceedings
Article
13 Jan 2026
New SPC Referral To The CJEU On The Interpretation Of Article 3(d)
Article
18 Dec 2025
EU Reaches Provisional Agreement On Reform For Regulatory Exclusivity Periods For Pharma Products
Article
08 Dec 2025
No Gold Standard But Still A Strict Approach On Added Matter From The UPC